Immune responses of chickens inoculated with a recombinant fowlpox vaccine coexpressing glycoprotein B of infectious laryngotracheitis virus and chicken IL-18

FEMS Immunology and Medical Microbiology

Volumn 63, Issue 2, 2011, Pages 289-295

  Chen, Hong Ying ^a   Cui, Pei ^b   Cui, Bao An ^a   Li, He Ping ^a   Jiao, Xian Qin ^a   Zheng, Lan Lan ^a   Cheng, Guo ^b   Chao, An Jun ^a  

^a HENAN AGRICULTURAL UNIVERSITY   (China)

^b Animal Husbandry Bureau of Henan Province   (China)

Author keywords

Chicken interleukin 18; GB gene; Infectious laryngotracheitis virus; Recombinant fowlpox virus

Indexed keywords

GLYCOPROTEIN B; INTERLEUKIN 18; RECOMBINANT FOWLPOX VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHICKEN; CONTROLLED STUDY; DRUG EFFICACY; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ILTOVIRUS; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; INOCULATION; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST;

ANIMALS; ANTIBODIES, VIRAL; CD4-CD8 RATIO; CELL PROLIFERATION; CHICKENS; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FOWLPOX VIRUS; GENETIC VECTORS; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 1, GALLID; INTERLEUKIN-18; POULTRY DISEASES; T-LYMPHOCYTES; VACCINATION; VACCINES, SYNTHETIC; VIRAL VACCINES;

EID: 80053909385     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2011.00850.x     Document Type: Article

References (30)

1. Chen HY, Zhao L, Wei ZY, Cui BA, Wang ZY, Li XS, Xia PA & Liu JP (2010) Enhancement of the immunogenicity of an infectious laryngotracheitis virus DNA vaccine by a bicistronic plasmid encoding glycoprotein B and interleukin-18. Antiviral Res 87: 235-241.
2. Davidson I, Nagar S, Ribshtein I, Shkoda I, Perk S & Garcia M (2009) Detection of wild- and vaccine-type avian infectious laryngotracheitis virus in clinical samples and feather shafts of commercial chickens. Avian Dis 53: 618-623.
3. Devlin JM, Browning GF, Hartley CA & Gilkerson JR (2007) Glycoprotein G deficient infectious laryngotracheitis virus is a candidate attenuated vaccine. Vaccine 25: 3561-3566.
4. Devlin JM, Browning GF, Gilkerson JR, Fenton SP & Hartley CA (2008) Comparison of the safety and protective efficacy of vaccination with glycoprotein-G-deficient infectious laryngotracheitis virus delivered via eye-drop, drinking water or aerosol. Avian Pathol 37: 83-88.
5. Devlin JM, Viejo-Borbolla A, Browning GF, Noormohammadi AH, Gilkerson JR, Alcami A & Hartley CA (2010) Evaluation of immunological responses to a glycoprotein G deficient candidate vaccine strain of infectious laryngotracheitis virus. Vaccine 28: 1325-1332.
6. Dufour-Zavala L (2008) Epizootiology of infectious laryngotracheitis and presentation of an industry control program. Avian Dis 52: 1-7.
7. Fuchs W, Veits J, Helferich D, Granzow H, Teifke JP & Mettenleiter TC (2007) Molecular biology of avian infectious laryngotracheitis virus. Vet Res 38: 261-279.
8. Guy JS & Bagust TJ (2003) Laryngotracheitis. Diseases of Poultry, 11th edn (Saif YM, ed), pp. 121-123. Iowa State Press, Ames, IA.
9. Jones RC (2010) Viral respiratory diseases (ILT, aMPV infections, IB): are they ever under control? Br Poult Sci 51: 1-11.
10. Lee LF, Bacon LD, Yoshida S, Yanagida N, Zhang HM & Witter RL (2004) The efficacy of recombinant fowlpox vaccine protection against Marek's disease: its dependence on chicken line and B haplotype. Avian Dis 48: 129-137.
11. Leong KH, Ramsay AJ, Boyle DB & Ramshaw IA (1994) Selective induction of immune responses by cytokines coexpressed in recombinant fowlpox virus. J Virol 68: 8125-8130.
12. Ma M, Jin N, Shen G et al. (2008) Immune responses of swine inoculated with a recombinant fowlpox virus co-expressing P12A and 3C of FMDV and swine IL-18. Vet Immunol Immunopathol 121: 1-7.
13. Marshall DJ, Rudnick KA, McCarthy SG, Mateo LR, Harris MC, McCauley C & Snyder LA (2006) Interleukin-18 enhances Th1 immunity and tumor protection of a DNA vaccine. Vaccine 24: 244-253.
14. Mingxiao M, Ningyi J, Zhenguo W et al. (2006). Construction and immunogenicity of recombinant fowlpox vaccines coexpressing HA of AIV H5N1 and chicken IL18. Vaccine 24: 4304-4311.
15. Nakanishi K, Yoshimoto T, Tsutsui H & Okamura H (2001) Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19: 423-474.
16. Noll A & Autenrieth IB (1996) Immunity against Yersinia enterocolitica by vaccination with Yersinia HSP60 immunostimulating complexes or Yersinia HSP60 plus interleukin-12. Infect Immun 64: 2955-2961.
17. Okamura H, Sakaguchi M, Honda T, Taneno A, Matsuo K & Yamada S (1994) Construction of recombinant infectious laryngotracheitis virus expressing the LacZ gene of E. coli with thymidine kinase gene. J Vet Med Sci 56: 799-801.
18. Park JH, Kim SJ, Oem JK, Lee KN, Kim YJ, Kye SJ, Park JY & Joo YS (2006) Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes. J Vet Sci 7: 257-262.
19. Pavlova SP, Veits J, Blohm U, Maresch C, Mettenleiter TC & Fuchs W (2010) In vitro and in vivo characterization of glycoprotein C-deleted infectious laryngotracheitis virus. J Gen Virol 91: 847-857.
20. Qiao C, Jiang Y, Tian G, Wang X, Li C, Xin X, Chen H & Yu K (2009) Recombinant fowlpox virus vector-based vaccine completely protects chickens from H5N1 avian influenza virus. Antiviral Res 81: 234-238.
21. Saade F, Buronfosse T, Pradat P, Abdul F & Cova L (2008) Enhancement of neutralizing humoral response of DNA vaccine against duck hepatitis B virus envelope protein by co-delivery of cytokine genes. Vaccine 26: 5159-5164.
22. Schneider K, Puehler F, Baeuerle D, Elvers S, Staeheli P, Kaspers B & Weining KC (2000) cDNA cloning of biologically active chicken interleukin-18. J Interferon Cytokine Res 20: 879-883.
23. Schnitzlein WM, Winans R, Ellsworth S & Tripathy DN (1995) Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology 209: 304-314.
24. Shen G, Jin N, Ma M et al. (2007) Immune responses of pigs inoculated with a recombinant fowlpox virus coexpressing GP5/GP3 of porcine reproductive and respiratory syndrome virus and swine IL-18. Vaccine 25: 4193-4202.
25. Su BS, Chiu HH, Lin CC, Shien JH, Yin HS & Lee LH (2011) Adjuvant activity of chicken interleukin-12 co-administered with infectious bursal disease virus recombinant VP2 antigen in chickens. Vet Immunol Immunopathol 139: 167-175.
26. Sun HL, Wang YF, Tong GZ, Zhang PJ, Miao DY, Zhi HD, Wang M & Wang M (2008) Protection of chickens from Newcastle disease and infectious laryngotracheitis with a recombinant fowlpox virus co-expressing the F, HN genes of Newcastle disease virus and gB gene of infectious laryngotracheitis virus. Avian Dis 52: 111-117.
27. Tan B, Wang H, Shang L & Yang T (2009) Coadministration of chicken GM-CSF with a DNA vaccine expressing infectious bronchitis virus (IBV) S1 glycoprotein enhances the specific immune response and protects against IBV infection. Arch Virol 154: 1117-1124.
28. Tong GZ, Zhang SJ, Wang L, Qiu HJ, Wang YF & Wang M (2001) Protection of chickens from infectious laryngotracheitis with a recombinant fowlpox virus expressing glycoprotein B of infectious laryngotracheitis virus. Avian Pathol 30: 143-148.
29. Wang YF, Sun YK, Tian ZC, Shi XM, Tong GZ, Liu SW, Zhi HD, Kong XG & Wang M (2009) Protection of chickens against infectious bronchitis by a recombinant fowlpox virus co-expressing IBV-S1 and chicken IFNgamma. Vaccine 27: 7046-7052.
30. York JJ & Fashey KJ (1991) Vaccination with affinity-purified glycoproteins protects chickens against infectious laryngotracheitis herpesvirus. Avian Pathol 20: 693-704.